Cargando…
Attacking Postoperative Metastases using Perioperative Oncolytic Viruses and Viral Vaccines
Surgical resection of solid primary malignancies is a mainstay of therapy for cancer patients. Despite being the most effective treatment for these tumors, cancer surgery has been associated with impaired metastatic clearance due to immunosuppression. In preclinical surgery models and human cancer p...
Autores principales: | Tai, Lee-Hwa, Auer, Rebecca |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4130104/ https://www.ncbi.nlm.nih.gov/pubmed/25161958 http://dx.doi.org/10.3389/fonc.2014.00217 |
Ejemplares similares
-
Perioperative oncolytic virotherapy to counteract surgery-induced immunosuppression and improve outcomes in pancreatic ductal adenocarcinoma
por: Mansouri, Sarah, et al.
Publicado: (2023) -
Oncolytic Viruses as Anticancer Vaccines
por: Woller, Norman, et al.
Publicado: (2014) -
Oncolytic Viral Therapy for Mesothelioma
por: Pease, Daniel F., et al.
Publicado: (2017) -
Herpes simplex virus 1 as an oncolytic viral therapy for refractory cancers
por: Scanlan, Hayle, et al.
Publicado: (2022) -
Oncolytic Adenovirus—A Nova for Gene-Targeted Oncolytic Viral Therapy in HCC
por: Abudoureyimu, Mubalake, et al.
Publicado: (2019)